By analogy with Tie2/HSV-TK-MSCs, after injection of these cells in the HCC mice model, CCL5/HSV-TK-MSC had more achievements in HCC tumor eradication, revealing that application of different promoter sequence is important in the anti-cancer effect of this strategy (120). The gene discussed is CCL5; the disease is hepatocellular carcinoma.